• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493919920300
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bradycardia (1751); Cardiac Arrest (1762); Chest Pain (1776); Death (1802); Dyspnea (1816); Non specific EKG/ECG Changes (1817); Ventricular Tachycardia (2132); Anxiety (2328); Diaphoresis (2452); Loss Of Pulse (2562)
Event Date 01/11/2017
Event Type  Death  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: the device was not returned for analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The most probable root cause was unable to be determined.(b)(4).
 
Event Description
(b)(6) clinical study.It was reported that the patient died.In (b)(6) 2013, clinical status assessment indicated that the patient's qualifying condition was unstable angina and prior to index procedure the patient was also found to have elevated biomarkers indicative of ischemia.Subsequently, the index procedure was performed.The target lesion was located in the ramus artery with 90% stenosis and was 15 mm long with a reference vessel diameter of 3.0 mm.The target lesion was treated with pre-dilatation and placement of a 3.00 x 20 mm study stent.Following post-dilatation, residual stenosis was 0%.On the following day, the patient was discharged on dual antiplatelet therapy.In (b)(6) 2017, the patient expired.The cause of death is unknown.
 
Manufacturer Narrative
(b)(4).
 
Event Description
Same patient as mdr id# 2134265-2017-07939 it was further reported that in january 2017, the patient presented to the emergency department for evaluation of chest pain.The patient complained of sternal chest pain and pain between shoulder blades with radiation down to the left arm associated with shortness of breath.The patient received aspirin, morphine sulphate and nitroglycerin in response to chest pain.While the patient was undergoing workup, the patient was noted to have ventricular tachycardia.An electorcardiogram (ekg) was performed which revealed prolongation of pulse rate (pr) interval, no acute ischemia.The patient was defibrillated and received epinephrine.Eventually, the patient was noted to have wide complex tachycardia.Additionally, the patient was moderately anxious and mildly diaphoretic.Ativan was given to calm the patient.Over the next 15 minutes, the patient had respiratory difficulty.Rapid sequence intubation medications were initiated; however, the patient was noted to be unresponsive and had pulseless electrical activity (pea).During intubation, copious secretions were noted.The secretions became more copious and pink frothy.Cardiopulmonary resuscitation (cpr) was continued.The patient received multiple doses of epinephrine and bicarbonate; however, the patient remained in pea and qrs complex was widened gradually.Cpr continued though the patient was unresponsive.The patient was noted to have a couple episodes of fine ventricular tachycardia with a wide complex.This was defibrillated a couple of times.After 20 minutes of second cardiac arrest, the patient was found to be in wide complex bradycardiac pea.Resuscitative efforts were discontinued.On the same day, the patient expired with manner of death reported as natural.Per death certificate, the immediate cause of death was cardiorespiratory arrest with underlying causes as ventricular tachycardia and coronary artery disease.An autopsy was not performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY¿
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6722217
MDR Text Key80327908
Report Number2134265-2017-07120
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/27/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/18/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/09/2013
Device Model NumberH7493919920300
Device Lot Number15671416
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/19/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/27/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age63 YR
-
-